Background Information:
Wellgistics Health, a pharmaceutical distribution company headquartered in Florida, announced its plan to integrate Ripple-associated cryptocurrency $XRP as a treasury asset and payment instrument within its financial operations. The company secured a $50 million Equity Line of Credit (ELOC) to support the integration of $XRP and its treasury reserve program.
Key Events:
Wellgistics intends to leverage $XRP and related technologies to enhance remittance speed among pharmacies, suppliers, and manufacturers while reducing settlement costs. Traditional Automated Clearing House (ACH) payments and wire transfers typically take about three days to complete and cost between $10 to $30, whereas $XRP transfer fees are less than one cent, with a transfer time of just 3-5 seconds.
The company believes that integrating $XRP will reduce settlement costs, enable real-time international payments, and improve transparency issues within the pharmaceutical supply chain. The financing is backed by a credit line from LDA Capital based in New York.
Industry Background and Impact:
This announcement comes as $XRP gains increasing institutional recognition. The Chicago Mercantile Exchange (CME) plans to launch cash-settled $XRP futures contracts later this month. Ripple recently acquired major brokerage firm Hidden Road for $1.25 billion, further expanding $XRP and its ledger applications within institutional contexts.
Additionally, the U.S. Securities and Exchange Commission (SEC) reached a $50 million settlement with Ripple, ending a long-standing legal dispute since 2020 and allowing Ripple to focus on business expansion.
SoSoValue Note: This article involves content related to SoSoValue.